Oncoprotein YAP regulates the spindle checkpoint activation in a mitotic phosphorylation-dependent manner through up-regulation of BubR1

Journal of Biological Chemistry

Volumn 290, Issue 10, 2015, Pages 6191-6202

  Yang, Shuping ^a,b   Zhang, Lin ^b   Chen, Xingcheng ^b   Chen, Yuanhong ^b   Dong, Jixin ^b  

^a SHANDONG UNIVERSITY   (China)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMICAL ACTIVATION; PROTEINS; TRANSCRIPTION;

CHECKPOINT ACTIVATION; EPITHELIAL CELLS; HYPERACTIVATION; MITOTIC PHOSPHORYLATION; POTENTIAL MECHANISM; PROTEIN KINASE; TRANSCRIPTIONAL CO-ACTIVATORS; UP-REGULATION;

PHOSPHORYLATION;

BUB1 RELATED PROTEIN; ONCOPROTEIN; PHOSPHOPROTEIN PHOSPHATASE CDC14; UNCLASSIFIED DRUG; YES ASSOCIATED PROTEIN; BUB1 PROTEIN, HUMAN; CDC14B PROTEIN, HUMAN; DUAL SPECIFICITY PHOSPHATASE; NUCLEAR PROTEIN; PROTEIN SERINE THREONINE KINASE; TRANSCRIPTION FACTOR; YY1AP1 PROTEIN, HUMAN;

ARTICLE; CELL INVASION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EPITHELIUM CELL; GENETIC ASSOCIATION; HUMAN; HUMAN CELL; IMMORTALIZED CELL LINE; M PHASE CELL CYCLE CHECKPOINT; MITOSIS INDEX; PANCREAS CELL; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; UPREGULATION; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; GENETICS; MCF 7 CELL LINE; METABOLISM; NEOPLASM; PATHOLOGY; PHOSPHORYLATION;

DUAL-SPECIFICITY PHOSPHATASES; GENE EXPRESSION REGULATION; HUMANS; M PHASE CELL CYCLE CHECKPOINTS; MCF-7 CELLS; NEOPLASMS; NUCLEAR PROTEINS; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84924943415     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.624411     Document Type: Article

References (59)

1. Zhao, B., Li, L., Lei, Q., and Guan, K. L. (2010) The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version. Genes Dev. 24, 862-874
2. Pan, D. (2010) The hippo signaling pathway in development and cancer. Dev. Cell 19, 491-505
3. Harvey, K. F., Zhang, X., and Thomas, D. M. (2013) The Hippo pathway and human cancer. Nat. Rev. Cancer 13, 246-257
4. Park, H. W., and Guan, K. L. (2013) Regulation of the Hippo pathway and implications for anticancer drug development. Trends Pharmacol. Sci. 34, 581-589
5. Johnson, R., and Halder, G. (2014) The two faces of Hippo: targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat. Rev. Drug Discov. 13, 63-79
6. Dong, J., Feldmann, G., Huang, J., Wu, S., Zhang, N., Comerford, S. A., Gayyed, M. F., Anders, R. A., Maitra, A., and Pan, D. (2007) Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130, 1120-1133
7. Camargo, F. D., Gokhale, S., Johnnidis, J. B., Fu, D., Bell, G. W., Jaenisch, R., and Brummelkamp, T. R. (2007) YAP1 increases organ size and expands undifferentiated progenitor cells. Curr. Biol. 17, 2054-2060
8. Overholtzer, M., Zhang, J., Smolen, G. A., Muir, B., Li, W., Sgroi, D. C., Deng, C. X., Brugge, J. S., and Haber, D. A. (2006) Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon. Proc. Natl. Acad. Sci. U.S.A. 103, 12405-12410
9. Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S. T., Luk, J. M., Wigler, M., Hannon, G. J., Mu, D., Lucito, R., Powers, S., and Lowe, S. W. (2006) Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach. Cell 125, 1253-1267
10. Steinhardt, A. A., Gayyed, M. F., Klein, A. P., Dong, J., Maitra, A., Pan, D., Montgomery, E. A., and Anders, R. A. (2008) Expression of Yes-associated protein in common solid tumors. Hum. Pathol. 39, 1582-1589
11. Fernandez-L, A., Northcott, P. A., Dalton, J., Fraga, C., Ellison, D., Angers, S., Taylor, M. D., and Kenney, A. M. (2009) YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation. Genes Dev. 23, 2729-2741
12. Xu, M. Z., Yao, T. J., Lee, N. P., Ng, I. O., Chan, Y. T., Zender, L., Lowe, S. W., Poon, R. T., and Luk, J. M. (2009) Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma. Cancer 115, 4576-4585
13. Zhao, B., Wei, X., Li, W., Udan, R. S., Yang, Q., Kim, J., Xie, J., Ikenoue, T., Yu, J., Li, L., Zheng, P., Ye, K., Chinnaiyan, A., Halder, G., Lai, Z. C., and Guan, K. L. (2007) Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev. 21, 2747-2761
14. Zhang, X., George, J., Deb, S., Degoutin, J. L., Takano, E. A., Fox, S. B., AOCS Study group, Bowtell, D. D., and Harvey, K. F. (2011) The Hippo pathway transcriptional co-activator, YAP, is an ovarian cancer oncogene. Oncogene 30, 2810-2822
15. Zhang, W., Nandakumar, N., Shi, Y., Manzano, M., Smith, A., Graham, G., Gupta, S., Vietsch, E. E., Laughlin, S. Z., Wadhwa, M., Chetram, M., Joshi, M., Wang, F., Kallakury, B., Toretsky, J., Wellstein, A., and Yi, C. (2014) Downstream of mutant KRAS, the transcription regulator YAP is essential for neoplastic progression to pancreatic ductal adenocarcinoma. Sci. Signal. 7, ra42
16. Siegel, J. J., and Amon, A. (2012) New insights into the troubles of aneuploidy. Annu. Rev. Cell Dev. Biol. 28, 189-214
17. Lara-Gonzalez, P., Westhorpe, F. G., and Taylor, S. S. (2012) The spindle assembly checkpoint. Curr. Biol. 22, R966-R980
18. Foley, E. A., and Kapoor, T. M. (2013) Microtubule attachment and spindle assembly checkpoint signalling at the kinetochore. Nat. Rev. Mol. Cell Biol. 14, 25-37
19. Jia, L., Kim, S., and Yu, H. (2013) Tracking spindle checkpoint signals from kinetochores to APC/C. Trends Biochem. Sci. 38, 302-311
20. Sotillo, R., Hernando, E., Díaz-Rodríguez, E., Teruya-Feldstein, J., Cordón-Cardo, C., Lowe, S. W., and Benezra, R. (2007) Mad2 overexpression promotes aneuploidy and tumorigenesis in mice. Cancer Cell 11, 9-23
21. Ricke, R. M., Jeganathan, K. B., and van Deursen, J. M. (2011) Bub1 over-expression induces aneuploidy and tumor formation through Aurora B kinase hyperactivation. J. Cell Biol. 193, 1049-1064
22. Schvartzman, J. M., Duijf, P. H., Sotillo, R., Coker, C., and Benezra, R. (2011) Mad2 is a critical mediator of the chromosome instability observed upon Rb and p53 pathway inhibition. Cancer Cell 19, 701-714
23. Yang, S., Zhang, L., Liu, M., Chong, R., Ding, S. J., Chen, Y., and Dong, J. (2013) CDK1 Phosphorylation of YAP promotes mitotic defects and cell motility and is essential for neoplastic transformation. Cancer Res. 73, 6722-6733
24. Mailand, N., Lukas, C., Kaiser, B. K., Jackson, P. K., Bartek, J., and Lukas, J. (2002) Deregulated human Cdc14A phosphatase disrupts centrosome separation and chromosome segregation. Nat. Cell Biol. 4, 317-322
25. Ramaswamy, S., Nakamura, N., Vazquez, F., Batt, D. B., Perera, S., Roberts, T. M., and Sellers, W. R. (1999) Regulation of G1 progression by the PTEN tumor suppressor protein is linked to inhibition of the phosphatidylinositol 3-kinase/Akt pathway. Proc. Natl. Acad. Sci. U.S.A. 96, 2110-2115
26. Lee, K. M., Yasuda, H., Hollingsworth, M. A., and Ouellette, M. M. (2005) Notch 2-positive progenitors with the intrinsic ability to give rise to pancreatic ductal cells. Lab. Invest. 85, 1003-1012
27. Xiao, L., Chen, Y., Ji, M., and Dong, J. (2011) KIBRA regulates Hippo signaling activity via interactions with large tumor suppressor kinases. J. Biol. Chem. 286, 7788-7796
28. Zhang, L., Iyer, J., Chowdhury, A., Ji, M., Xiao, L., Yang, S., Chen, Y., Tsai, M. Y., and Dong, J. (2012) KIBRA regulates aurora kinase activity and is required for precise chromosome alignment during mitosis. J. Biol. Chem. 287, 34069-34077
29. Ji, M., Yang, S., Chen, Y., Xiao, L., Zhang, L., and Dong, J. (2012) Phospho-regulation of KIBRA by CDK1 and CDC14 phosphatase controls cell-cycle progression. Biochem. J. 447, 93-102
30. Xiao, L., Chen, Y., Ji, M., Volle, D. J., Lewis, R. E., Tsai, M. Y., and Dong, J. (2011) KIBRA protein phosphorylation is regulated by mitotic kinase aurora and protein phosphatase 1. J. Biol. Chem. 286, 36304-36315
31. Yang, S., Ji, M., Zhang, L., Chen, Y., Wennmann, D. O., Kremerskothen, J., and Dong, J. (2014) Phosphorylation of KIBRA by the extracellular signal-regulated kinase (ERK)-ribosomal S6 kinase (RSK) cascade modulates cell proliferation and migration. Cell Signal. 26, 343-351
32. Visintin, R., Craig, K., Hwang, E. S., Prinz, S., Tyers, M., and Amon, A. (1998) The phosphatase Cdc14 triggers mitotic exit by reversal of Cdk-dependent phosphorylation. Mol. Cell 2, 709-718
33. Li, L., Ljungman, M., and Dixon, J. E. (2000) The human Cdc14 phosphatases interact with and dephosphorylate the tumor suppressor protein p53. J. Biol. Chem. 275, 2410-2414
34. Esteban, V., Vázquez-Novelle, M. D., Calvo, E., Bueno, A., and Sacristán, M. P. (2006) Human Cdc14A reverses CDK1 phosphorylation of Cdc25A on serines 115 and 320. Cell Cycle. 5, 2894-2898
35. Bembenek, J., and Yu, H. (2001) Regulation of the anaphase-promoting complex by the dual specificity phosphatase human Cdc14a. J. Biol. Chem. 276, 48237-48242
36. Gray, C. H., Good, V. M., Tonks, N. K., and Barford, D. (2003) The structure of the cell cycle protein Cdc14 reveals a proline-directed protein phosphatase. EMBO J. 22, 3524-3535
37. Hansen, C. A., Bartek, J., and Jensen, S. (2008) A functional link between the human cell cycle-regulatory phosphatase Cdc14A and the atypical mitogen-activated kinase Erk3. Cell Cycle. 7, 325-334
38. Lanzetti, L., Margaria, V., Melander, F., Virgili, L., Lee, M. H., Bartek, J., and Jensen, S. (2007) Regulation of the Rab5 GTPase-activating protein RN-tre by the dual specificity phosphatase Cdc14A in human cells. J. Biol. Chem. 282, 15258-15270
39. Tumurbaatar, I., Cizmecioglu, O., Hoffmann, I., Grummt, I., and Voit, R. (2011) Human Cdc14B promotes progression through mitosis by dephosphorylating Cdc25 and regulating Cdk1/cyclin B activity. PLoS One 6, e14711
40. 2/M transition through Cdc25A and Cdc25B. J. Biol. Chem. 285, 40544-40553
41. Bharadwaj, R., and Yu, H. (2004) The spindle checkpoint, aneuploidy, and cancer. Oncogene 23, 2016-2027
42. Xin, M., Kim, Y., Sutherland, L. B., Qi, X., McAnally, J., Schwartz, R. J., Richardson, J. A., Bassel-Duby, R., and Olson, E. N. (2011) Regulation of insulin-like growth factor signaling by Yap governs cardiomyocyte proliferation and embryonic heart size. Sci. Signal. 4, ra70
43. Schlegelmilch, K., Mohseni, M., Kirak, O., Pruszak, J., Rodriguez, J. R., Zhou, D., Kreger, B. T., Vasioukhin, V., Avruch, J., Brummelkamp, T. R., and Camargo, F. D. (2011) Yap1 acts downstream of α-catenin to control epidermal proliferation. Cell 144, 782-795
44. Anand, S., Penrhyn-Lowe, S., and Venkitaraman, A. R. (2003) AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol. Cancer Cell 3, 51-62
45. Cui, Y., and Guadagno, T. M. (2008) B-Raf(V600E) signaling deregulates the mitotic spindle checkpoint through stabilizing Mps1 levels in melanoma cells. Oncogene 27, 3122-3133
46. Kops, G. J., Weaver, B. A., and Cleveland, D. W. (2005) On the road to cancer: aneuploidy and the mitotic checkpoint. Nat. Rev. Cancer 5, 773-785
47. Storchova, Z., and Pellman, D. (2004) From polyploidy to aneuploidy, genome instability and cancer. Nat. Rev. Mol. Cell Biol. 5, 45-54
48. Varelas, X. (2014) The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease. Development 141, 1614-1626
49. Yabuta, N., Okada, N., Ito, A., Hosomi, T., Nishihara, S., Sasayama, Y., Fujimori, A., Okuzaki, D., Zhao, H., Ikawa, M., Okabe, M., and Nojima, H. (2007) Lats2 is an essential mitotic regulator required for the coordination of cell division. J. Biol. Chem. 282, 19259-19271
50. Hergovich, A., Kohler, R. S., Schmitz, D., Vichalkovski, A., Cornils, H., and Hemmings, B. A. (2009) The MST1 and hMOB1 tumor suppressors control human centrosome duplication by regulating NDR kinase phosphorylation. Curr. Biol. 19, 1692-1702
51. Chiba, S., Ikeda, M., Katsunuma, K., Ohashi, K., and Mizuno, K. (2009) MST2- and Furry-mediated activation of NDR1 kinase is critical for precise alignment of mitotic chromosomes. Curr. Biol. 19, 675-681
52. Oh, H. J., Kim, M. J., Song, S. J., Kim, T., Lee, D., Kwon, S. H., Choi, E. J., and Lim, D. S. (2010) MST1 limits the kinase activity of aurora B to promote stable kinetochore-microtubule attachment. Curr. Biol. 20, 416-422
53. Mardin, B. R., Lange, C., Baxter, J. E., Hardy, T., Scholz, S. R., Fry, A. M., and Schiebel, E. (2010) Components of the Hippo pathway cooperate with Nek2 kinase to regulate centrosome disjunction. Nat. Cell Biol. 12, 1166-1176
54. Florindo, C., Perdigão, J., Fesquet, D., Schiebel, E., Pines, J., and Tavares, A. A. (2012) Human Mob1 proteins are required for cytokinesis by controlling microtubule stability. J. Cell Sci. 125, 3085-3090
55. Shimizu, T., Ho, L. L., and Lai, Z. C. (2008) The mob as tumor suppressor gene is essential for early development and regulates tissue growth in Drosophila. Genetics 178, 957-965
56. Yamamoto, Y., Matsuyama, H., Chochi, Y., Okuda, M., Kawauchi, S., Inoue, R., Furuya, T., Oga, A., Naito, K., and Sasaki, K. (2007) Overexpression of BUBR1 is associated with chromosomal instability in bladder cancer. Cancer Genet. Cytogenet. 174, 42-47
57. Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., Powell, J. I., Yang, L., Marti, G. E., Moore, T., Hudson, J.,Jr, Lu, L., Lewis, D. B., Tibshirani, R., Sherlock, G., Chan, W. C., Greiner, T. C., Weisenburger, D. D., Armitage, J. O., Warnke, R., Levy, R., Wilson, W., Grever, M. R., Byrd, J. C., Botstein, D., Brown, P. O., and Staudt, L. M. (2000) Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature 403, 503-511
58. Chen, X., Cheung, S. T., So, S., Fan, S. T., Barry, C., Higgins, J., Lai, K. M., Ji, J., Dudoit, S., Ng, I. O., Van De Rijn, M., Botstein, D., and Brown, P. O. (2002) Gene expression patterns in human liver cancers. Mol. Biol. Cell 13, 1929-1939
59. Garber, M. E., Troyanskaya, O. G., Schluens, K., Petersen, S., Thaesler, Z., Pacyna-Gengelbach, M., van de Rijn, M., Rosen, G. D., Perou, C. M., Whyte, R. I., Altman, R. B., Brown, P. O., Botstein, D., and Petersen, I. (2001) Diversity of gene expression in adenocarcinoma of the lung. Proc. Natl. Acad. Sci. U.S.A. 98, 13784-13789